Western blot (protocol section 6) is the most expedient way to preliminarily assess the success of an experiment. When membranes are probed with streptavidin-HRP, lysate from cells where all components of the system were present should contain a band corresponding to biotinylated L31-FTA (Figure 2A, lane 20). The same band should be present, usually at greater intensity, if cells were transfected with full-length BirA as a positive control (Figure 2A, lanes 1–4). This band should be fainter or absent in samples where one or more system components was omitted (Figure 2A, all other lanes). Since mammalian cells contain several endogenous biotinylated carboxylase proteins in the 70–80 and 120–130 kDa range34,35, we typically see bands at these molecular weights in all lysate samples. Membranes can also be probed with anti-V5 antibody to confirm expression of the split BirA fragments.
Western blot of the lysate, flowthrough, and eluate samples can assess whether an affinity purification experiment was successful (Figure 2B). A decrease in biotinylated L31-FTA in the flowthrough relative to the lysate indicates that a substantial proportion of the biotinylated ribosomes were captured by affinity purification. Since streptavidin conjugates to AviTag distal to the TEV cleavage site on L31-FTA, the biotinylated portion of L31-FTA is cleaved during TEV-mediated elution and thus, no biotinylated L31-FTA should be present in the eluate. L31-FTA in the non-biotinylated, biotinylated, and TEV-cleaved states are all detectable by anti-FLAG antibody, which should reveal that the eluate contains a cleaved L31-FTA band at a slightly lower molecular weight than intact L31-FTA. Note that the L31-FTA bands in the lysate and flow-through will often have comparable intensity when probed with anti-FLAG antibody; since activation is performed briefly, only a small fraction of total L31-FTA is biotinylated and affinity-captured. Probing for other ribosomal proteins such as Rps12 demonstrates the presence of the small ribosomal subunit in the eluate, suggesting that affinity purification of biotinylated L31-FTA captures whole ribosomes. Conversely, probing with anti-V5 antibody shows that proteins that do not bind the ribosome, such as the split BirA fragments themselves, are absent from the eluate.
Determining the optimal bead:lysate ratio is important, and Figure 2C demonstrates the diminishing utility of increasing the amount of lysate beyond the capacity of the beads. In this experiment, 2.5-fold more lysate was used with the same 450 µL of streptavidin-coated beads. Consequently, a substantial amount of biotinylated L31-FTA remained in the flowthrough. This occurred in part because the endogenous biotinylated proteins also occupy binding sites on the streptavidin-coated beads, as demonstrated by their partial depletion in the flowthrough. The endogenous biotinylated proteins are not detectable in the eluate because they are not released from the beads during TEV-mediated elution, but they are recovered when post-elution beads are heated in Laemmli buffer.
Immunofluorescence images showing split enzyme localization to targeted organelles, as well as results from other system-based experiments such as RNA-seq and MS proteomics of eluates, can be found in our recent publication30.

Figure 1: Schematic for ALIBi components and experiment workflow. (A) Role of each component during activation, affinity purification, and elution. (B) Position of FLAG-TEV-AviTag in the Rpl31 coding sequence, and position of Rpl31 on the structure of the ribosome (PDB 4V6X). (C) Structure of the N-fragment (pink) and C-fragment (purple) of split BirA enzyme, with the arrowhead denoting the split site (PDB 1BIB). (D) Examples of construct pairs used to target the split BirA enzyme fragments to organelles. (E) Timeline of a typical experiment. This figure was adapted from Zhang et al.30. Abbreviations: ? = hypothetical copurifying proteins; ALIBi = AviTag-specific Location-restricted Illumination-enhanced Biotinylation; TEV = tobacco etch virus; MS = mass spectrometry; CDS = coding sequence; ER = endoplasmic reticulum; eMag = enhanced Magnet; NES = nuclear export sequence; MAVS = mitochondrial antiviral-signaling protein. Adapted with permission from Zhang et al.30. Please click here to view a larger version of this figure.

Figure 2: Representative western blot results. (A) Biotinylation of L31-FTA, as detected by streptavidin-HRP, under conditions including different combinations of ALIBi components. anti-V5 antibody detects the N- and C-terminal fragments at lower and higher molecular weights, respectively. GAPDH serves as a loading control. Full-length BirA serves as a positive control. Lanes with GFP expressed in lieu of split enzymes, or with untagged mESCs, serve as negative controls. This panel was adapted from Zhang et al.30 (B) Abundance of biotinylated L31-FTA (detected by streptavidin-HRP), total L31-FTA (detected by anti-FLAG antibody), split enzyme fragments (detected by anti-V5 antibody), and the ribosomal small subunit protein Rps12 in lysate, flowthrough, and eluate fractions. Percentages indicate the proportion of the total sample volume that was loaded. (C) Abundance of biotinylated L31-FTA, total L31-FTA, and split enzyme fragments in fractions from an affinity pulldown experiment in which 2.5x the amount of lysate was used with the standard 450 μL of streptavidin-coated beads. For lane 4, the beads after elution were heated at 95 °C for 10 min in 450 μL of 1x Laemmli buffer. Abbreviations: ALIBi = AviTag-specific Location-restricted Illumination-enhanced Biotinylation; HRP = horseradish peroxidase; GFP = green fluorescent protein; mESCs = mouse embryonic stem cells. Panel (A) is adapted with permission from Zhang et al.30. Please click here to view a larger version of this figure.
Table 1: Subcellular localization sequences. Peptide sequences used to target the split enzymes to organelles of interest36,37,38,39,40,41. Adapted with permission from Zhang et al.30.Please click here to download this Table.
Table 2: Buffer recipes. Includes buffers used for cell culture, cell lysis, affinity purification/elution, and western blot. Please click here to download this Table.
Table 3: Western blot conditions. Includes probe/antibody dilutions and conditions for blocking, wash, and probe/antibody incubation steps. Please click here to download this Table.
Supplemental File 1: Example strategy for inserting FTA into an endogenous ribosomal protein gene via CRISPR. Please click here to download this file.
Supplemental Figure S1: Example CRISPR strategy for insertion of FLAG-TEV-AviTag into an endogenous ribosomal protein gene. Two PX459-based plasmids, which each express a Cas9 protein fused to T2A and a puromycin resistance protein, as well as a guide RNA, are transfected into wild-type mESCs to yield two Cas9-gRNAs. Simultaneously, a donor plasmid is also transfected. The Cas9-gRNAs then cut the genomic DNA at sites surrounding the stop codon and the donor plasmid to release a linearized dsDNA repair template. This allows for homology-directed repair of the genomic DNA. In the successfully edited genomic DNA, the original gRNA cut sites now harbor mutations to prevent re-cutting. Abbreviations: CRISPR = clustered regularly interspaced short palindromic repeats; TEV = tobacco etch virus; puroR = puromycin resistance protein; gRNA = guide RNA; mESCs = mouse embryonic stem cells; RP = ribosomal protein. Please click here to download this file.
Supplemental Figure S2: Recommended primer design for genotype screening of post-CRISPR clones. Configurations A and B are recommended primer placements, where at least one primer in each pair is distal to the 300 bp flanking regions. Configuration C is not recommended, due to the risk of a false positive from amplification of residual donor plasmid. Abbreviations: CRISPR = clustered regularly interspaced short palindromic repeats; gRNA = guide RNA; RP = ribosomal protein. Please click here to download this file.